Cue Biopharma (CUE)
(Delayed Data from NSDQ)
$0.52 USD
-0.04 (-7.26%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.52 0.00 (-0.76%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | 31.03% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.87 |
Next Year | -0.73 |
EPS (TTM) | -0.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.07M | 4.75M | 11.48M | 8.44M |
# of Estimates | 4 | 4 | 3 | 4 |
High Estimate | 2.08M | 15.20M | 19.80M | 23.75M |
Low Estimate | 0.20M | 1.00M | 6.38M | 2.00M |
Year ago Sales | 2.10M | 1.82M | 5.49M | 11.48M |
Year over Year Growth Est. | -49.05% | 160.99% | 109.11% | -26.51% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.17 | -0.87 | -0.73 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.18 | 0.03 | -0.54 | -0.54 |
Low Estimate | -0.27 | -0.30 | -1.20 | -0.86 |
Year ago EPS | -0.24 | -0.28 | -1.11 | -0.87 |
Year over Year Growth Est. | 8.33% | 39.29% | 21.62% | 15.52% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.17 | -0.87 | -0.73 |
7 Days Ago | -0.22 | -0.17 | -0.87 | -0.73 |
30 Days Ago | -0.22 | -0.17 | -0.87 | -0.73 |
60 Days Ago | -0.25 | -0.20 | -0.97 | -0.92 |
90 Days Ago | -0.25 | -0.20 | -0.97 | -0.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.17 | -0.87 | -0.73 |
Zacks Consensus Estimate | -0.22 | -0.17 | -0.87 | -0.73 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.25 | -0.28 | -0.24 | NA |
Estimate | -0.29 | -0.30 | NA | -0.30 | NA |
Difference | 0.09 | 0.05 | NA | 0.06 | 0.07 |
Surprise | 31.03% | 16.67% | NA | 20.00% | 22.57% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more